Gene · 94241
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. | Front Genet | 2023 | 38259614 | PubTator, text mining | PubMed |
| Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model. | Front Pharmacol | 2023 | 38235109 | PubTator, text mining | PubMed |
| The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms. | Int J Mol Sci | 2023 | 38203290 | PubTator, text mining | PubMed |
| miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. | Cells | 2023 | 38201290 | PubTator, text mining | PubMed |
| The role of ncRNA regulatory mechanisms in diseases-case on gestational diabetes. | Brief Bioinform | 2023 | 38189542 | PubTator, text mining | PubMed |
| miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology. | Rep Pract Oncol Radiother | 2023 | 38179293 | PubTator, text mining | PubMed |
| Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data. | Transl Psychiatry | 2023 | 38092781 | PubTator, text mining | PubMed |
| Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy. | Genome Med | 2023 | 38087308 | PubTator, text mining | PubMed |
| Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer. | Front Oncol | 2023 | 38074657 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles: A potential treatment for regeneration. | iScience | 2023 | 38026170 | PubTator, text mining | PubMed |
| Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias. | Sci Adv | 2023 | 38019903 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia. | Brain Sci | 2023 | 38002537 | PubTator, text mining | PubMed |
| MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. | Biomedicines | 2023 | 38002007 | PubTator, text mining | PubMed |
| Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis. | J Orthop Surg Res | 2023 | 37993867 | PubTator, text mining | PubMed |
| Identification and verification of m6A-related miRNAs correlated with prognosis and immune microenvironment in colorectal cancer. | Medicine (Baltimore) | 2023 | 37986290 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. | Genome Med | 2023 | 37978395 | PubTator, text mining | PubMed |
| Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | 37965449 | PubTator, text mining | PubMed |
| MicroRNA-200 Loaded Lipid Nanoparticles Promote Intestinal Epithelium Regeneration in Canonical MicroRNA-Deficient Mice. | ACS Nano | 2023 | 37939210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94241/papers?page=5